Treatment Outcomes of Well‐Differentiated High‐Grade Neuroendocrine Tumors

INTRODUCTION: Recent classification of neuroendocrine neoplasms has defined well‐differentiated high‐grade neuroendocrine tumors (NET G3) as a distinct entity from poorly differentiated neuroendocrine carcinoma. The optimal treatment for NET G3 has not been well‐described. This study aimed to evalua...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Liu, Alex J., Ueberroth, Benjamin E., McGarrah, Patrick W., Buckner Petty, Skye A., Kendi, Ayse Tuba, Starr, Jason, Hobday, Timothy J., Halfdanarson, Thorvardur R., Sonbol, Mohamad Bassam
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2021
Matèries:
Gastrointestinal Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100548/
https://ncbi.nlm.nih.gov/pubmed/33496040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13686
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars